Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk
By A Mystery Man Writer
Description
Advances in sequencing technology have made multigene testing, or “panel testing,” a practical option when looking for genetic variants that may be associated with a risk of breast cancer. In June
Frontiers Precise, Genotype-First Breast Cancer Prevention: Experience With Transferring Monogenic Findings From a Population Biobank to the Clinical Setting
PALB2 – Inherited Cancer Registry (ICARE)
The role of NGS in breast cancer diagnosis and treatment
Results of multigene panel testing in familial cancer cases without genetic cause demonstrated by single gene testing
Frontiers Complex Landscape of Germline Variants in Brazilian Patients With Hereditary and Early Onset Breast Cancer
Who needs breast cancer genetics testing?
Economic impact of multigene panel testing for hereditary breast and ovarian cancer
Genes, Free Full-Text
Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer, BMC Cancer
BREAST CANCER PRS (Polygenic Risk Score) –
from
per adult (price varies by group size)